Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
therapeutic tumor infiltrating lymphocytes
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I/II Study of Adoptive Immunotherapy Utilizing Activated Marrow Infiltrating Lymphocytes in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation for Newly Diagnosed Stage II or III Multiple Myeloma
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
JHOC-J0770
, J0770, NCT00566098
2.
Phase I/II Study of 2G-1 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes or Tumor Infiltrating Lymphocytes and Aldesleukin After a Nonmyeloablative Preparative Chemotherapy Regimen in Patients With Metastatic Renal Cell Carcinoma
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-09-C-0092
, 09-C-0092, NCI-P08417, NCT00870389
3.
Phase II Study of Adoptive Transfer of Cloned Lymphocytes With Interleukin-2 After Cyclophosphamide and Fludarabine in Patients With Metastatic Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
16 and over
Sponsor:
NCI
Protocol IDs:
NCI-99-C-0158
, NCI-T99-0078, T99-0078, NCT00019942
4.
Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors
Phase:
Phase II
Type:
Treatment
Status:
Approved-not yet active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
CD-2007-01
, NCT00610389
5.
Phase II Study of Short-Term Cultured Autologous Tumor-Infiltrating Lymphocytes in Combination With High-Dose Aldesleukin After a Nonmyeloablative Lymphocyte-Depleting Conditioning Regimen Comprising Cyclophosphamide and Fludarabine Phosphate in Patients With Metastatic Melanoma
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
STLMC-L-0839
, L-08-39, NCT00863330
6.
Phase I Pilot Study of Adoptive Cell Therapy Comprising Tumor-Derived Lymphocytes in Patients With Persistent or Recurrent B-Cell Lymphoid Malignancies After Prior Allogeneic Hematopoietic Stem Cell Transplantation
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 to 75
Sponsor:
NCI
Protocol IDs:
NCI-07-C-0064
, NCT00445666
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute